Cargando…

Emerging therapies for non-small cell lung cancer

Recent advances in the field of novel anticancer agents prolong patients’ survival and show a promising future. Tyrosine kinase inhibitors and immunotherapy for lung cancer are the two major areas undergoing rapid development. Although increasing novel anticancer agents were innovated, how to transl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chao, Leighl, Natasha B., Wu, Yi-Long, Zhong, Wen-Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482588/ https://www.ncbi.nlm.nih.gov/pubmed/31023335 http://dx.doi.org/10.1186/s13045-019-0731-8

Ejemplares similares

Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer
por: Corke, Lucy K., et al.
Publicado: (2022)

Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice
por: Martin, Petra, et al.
Publicado: (2017)

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine
por: Soldera, Sara Victoria, et al.
Publicado: (2017)

The effect of prior cancer on non‐small cell lung cancer trial eligibility
por: Herman, Michael, et al.
Publicado: (2021)

The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer
por: Zhong, Wen-Zhao, et al.
Publicado: (2017)

Emerging evidence and treatment paradigm of non-small cell lung cancer
por: Liu, Si-Yang Maggie, et al.
Publicado: (2023)

The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
por: Zhang, Yi-Chen, et al.
Publicado: (2017)

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
por: Li, Shenduo, et al.
Publicado: (2023)

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer
por: Ionescu, Diana N., et al.
Publicado: (2022)

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
por: Kang, Jin, et al.
Publicado: (2021)

Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysis
por: Zhang, Chao, et al.
Publicado: (2021)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer
por: Puri, Sonam, et al.
Publicado: (2020)

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
por: Melosky, Barbara, et al.
Publicado: (2021)

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
por: Barnes, Tristan A., et al.
Publicado: (2017)

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
por: Yuan, Min, et al.
Publicado: (2019)

Emerging therapies for small cell lung cancer
por: Yang, Sen, et al.
Publicado: (2019)

Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer
por: Tian, Wentao, et al.
Publicado: (2020)

The Emerging Importance of Tumor Genomics in Operable Non-Small Cell Lung Cancer
por: Lengel, Harry B., et al.
Publicado: (2021)

Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in Canada
por: Perdrizet, Kirstin, et al.
Publicado: (2021)

RADI-08. A SURVEY BASED STUDY OF BRAIN METASTASES MANAGEMENT FOR PATIENTS WITH NON-SMALL CELL LUNG CANCERS OR MELANOMA
por: Fong, Chin Heng, et al.
Publicado: (2019)

HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies
por: Uy, Natalie F., et al.
Publicado: (2022)

Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
por: Patel, Yuti P., et al.
Publicado: (2021)

Emerging role of SIRT2 in non-small cell lung cancer
por: Zheng, Mengge, et al.
Publicado: (2021)

Ancillary Testing in Lung Cancer Diagnosis
por: Dubinski, William, et al.
Publicado: (2012)

Emerging therapeutic agents for advanced non-small cell lung cancer
por: Chen, Ruqin, et al.
Publicado: (2020)

Emerging Options for the Management of Non-Small Cell Lung Cancer
por: Binder, Daniel, et al.
Publicado: (2013)

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
por: Salgia, Ravi, et al.
Publicado: (2021)

Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy
por: Hao, Desirée, et al.
Publicado: (2020)

Emerging roles of Nrf2 signal in non-small cell lung cancer
por: Tian, Yijun, et al.
Publicado: (2016)

The Evolution of Therapies in Non-Small Cell Lung Cancer
por: Boolell, Vishal, et al.
Publicado: (2015)

Vaccine Therapy in Non-Small Cell Lung Cancer
por: García-Pardo, Miguel, et al.
Publicado: (2022)

Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
por: Eggen, Annemarie C, et al.
Publicado: (2021)

Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of China
por: Gou, Lan-Ying, et al.
Publicado: (2014)

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
por: Boland, William, et al.
Publicado: (2010)

Emerging roles of circular RNAs in non-small cell lung cancer
por: Li, Shanshan, et al.
Publicado: (2021)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

Origins, genetic landscape, and emerging therapies of small cell lung cancer
por: Semenova, Ekaterina A., et al.
Publicado: (2015)

Small Cell Lung Cancer: Emerging Targets and Strategies for Precision Therapy
por: Patel, Shruti R., et al.
Publicado: (2023)

Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
por: Qiu, Zhenbin, et al.
Publicado: (2019)

Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
por: Sung, Mike, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3094fhu6n62omls0upimaell13